APIs, Excipients, and Manufacturing eBook
Read the article:
Containing and Enhancing Potent Particles with Micronization
Read the ebook:
Pharmaceutical Technology APIs, Excipients, and Manufacturing eBook
CONTINUE TO SITE
OR WAIT null SECS
Advertisement
- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Containing and Enhancing Potent Particles with Micronization
A multilayered processing approach ensures safe handling and content uniformity of highly potent APIs.
Micronization is an important tool for developing new drugs, its primary advantage being that it is scalable from the early stages of development through to commercial volumes. The micronization process is both well-understood and cost-effective.
With the increased number of potent drugs in development, having the capabilities to handle and process them is becoming imperative. Development partners with the specialized expertise and infrastructure required to handle potent APIs play a key role in the supply chain of next generation medicines.
Read this article in Pharmaceutical Technology’s October 2021 APIs, Excipients, and Manufacturing eBook.
Advertisement
About the Author
Andy Maitland is operations and supply chain director, Catalent.
Article Details
Pharmaceutical Technology
eBook: APIs, Excipients, and Manufacturing
October 2021
Pages: 30–35
Citation
When referring to this article, please cite it as A. Maitland, “Containing and Enhancing Potent Particles with Micronization,” Pharmaceutical Technology APIs, Excipients, and Manufacturing eBook (October 2021).
